Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1645 to 1647 of 1647 entries
Sorted by: Best Match Show Resources per page
Empiric antibiotics for community-acquired pneumonia in adult patients: a systematic review and a network meta-analysis.

Thorax

Montes-Andujar L, Tinoco E, Baez-Pravia O, Martin-Saborido C, Blanco-Schweizer P, Segura C, Prol Silva E, Reyes V, Rodriguez Cobo A, Zurdo C, Angel V, Varona O, Valero J, Suarez Del Villar R, Ortiz G, Villanueva J, Menéndez J, Blanco J, Torres A, Cardinal-Fernández PA.
PMID: 33723019
Thorax. 2021 Oct;76(10):1020-1031. doi: 10.1136/thoraxjnl-2019-214054. Epub 2021 Mar 15.

OBJECTIVE: The main aim of this network meta-analysis is to identify the empiric antibiotic (Em-ATB) with the highest probability of being the best (HPBB) in terms of (1) cure rate and (2) mortality rate in hospitalised patients with community...

Cite
Montes-Andujar L, Tinoco E, Baez-Pravia O, et al. Empiric antibiotics for community-acquired pneumonia in adult patients: a systematic review and a network meta-analysis. Thorax. 2021;76(10):1020-1031doi: 10.1136/thoraxjnl-2019-214054.
Montes-Andujar, L., Tinoco, E., Baez-Pravia, O., Martin-Saborido, C., Blanco-Schweizer, P., Segura, C., Prol Silva, E., Reyes, V., Rodriguez Cobo, A., Zurdo, C., Angel, V., Varona, O., Valero, J., Suarez Del Villar, R., Ortiz, G., Villanueva, J., Menéndez, J., Blanco, J., Torres, A., & Cardinal-Fernández, P. A. (2021). Empiric antibiotics for community-acquired pneumonia in adult patients: a systematic review and a network meta-analysis. Thorax, 76(10), 1020-1031. https://doi.org/10.1136/thoraxjnl-2019-214054
Montes-Andujar, Lara, et al. "Empiric antibiotics for community-acquired pneumonia in adult patients: a systematic review and a network meta-analysis." Thorax vol. 76,10 (2021): 1020-1031. doi: https://doi.org/10.1136/thoraxjnl-2019-214054
Montes-Andujar L, Tinoco E, Baez-Pravia O, Martin-Saborido C, Blanco-Schweizer P, Segura C, Prol Silva E, Reyes V, Rodriguez Cobo A, Zurdo C, Angel V, Varona O, Valero J, Suarez Del Villar R, Ortiz G, Villanueva J, Menéndez J, Blanco J, Torres A, Cardinal-Fernández PA. Empiric antibiotics for community-acquired pneumonia in adult patients: a systematic review and a network meta-analysis. Thorax. 2021 Oct;76(10):1020-1031. doi: 10.1136/thoraxjnl-2019-214054. Epub 2021 Mar 15. PMID: 33723019.
Copy Download .nbib Format: NLM
Soluble CD95L in cancers and chronic inflammatory disorders, a new therapeutic target?.

Biochimica et biophysica acta. Reviews on cancer

Kurma K, Boizard-Moracchini A, Galli G, Jean M, Vacher P, Blanco P, Legembre P.
PMID: 34324950
Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188596. doi: 10.1016/j.bbcan.2021.188596. Epub 2021 Jul 26.

Although CD95L (also known as FasL) is still predominantly considered as a death ligand that induces apoptosis in infected and transformed cells, substantial evidence indicate that it can also trigger non-apoptotic signaling pathways whose pathophysiological roles remain to be...

Cite
Kurma K, Boizard-Moracchini A, Galli G, et al. Soluble CD95L in cancers and chronic inflammatory disorders, a new therapeutic target?. Biochim Biophys Acta Rev Cancer. 2021;1876(2):188596doi: 10.1016/j.bbcan.2021.188596.
Kurma, K., Boizard-Moracchini, A., Galli, G., Jean, M., Vacher, P., Blanco, P., & Legembre, P. (2021). Soluble CD95L in cancers and chronic inflammatory disorders, a new therapeutic target?. Biochimica et biophysica acta. Reviews on cancer, 1876(2), 188596. https://doi.org/10.1016/j.bbcan.2021.188596
Kurma, Keerthi, et al. "Soluble CD95L in cancers and chronic inflammatory disorders, a new therapeutic target?." Biochimica et biophysica acta. Reviews on cancer vol. 1876,2 (2021): 188596. doi: https://doi.org/10.1016/j.bbcan.2021.188596
Kurma K, Boizard-Moracchini A, Galli G, Jean M, Vacher P, Blanco P, Legembre P. Soluble CD95L in cancers and chronic inflammatory disorders, a new therapeutic target?. Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188596. doi: 10.1016/j.bbcan.2021.188596. Epub 2021 Jul 26. PMID: 34324950.
Copy Download .nbib Format: NLM
Performance of a Point of Care Test for Detecting IgM and IgG Antibodies Against SARS-CoV-2 and Seroprevalence in Blood Donors and Health Care Workers in Panama.

Frontiers in medicine

Villarreal A, Rangel G, Zhang X, Wong D, Britton G, Fernandez PL, Pérez A, Oviedo D, Restrepo C, Carreirra MB, Sambrano D, Eskildsen GA, De La Guardia C, Flores-Cuadra J, Carrera JP, Zaldivar Y, Franco D, López-Vergès S, Zhang D, Fan F, Wang B, Sáez-Llorens X, DeAntonio R, Torres-Atencio I, Blanco I, Subía FD, Mudarra L, Benzadon A, Valverde W, López L, Hurtado N, Rivas N, Jurado J, Carvallo A, Rodriguez J, Perez Y, Morris J, Luque O, Cortez D, Ortega-Barria E, Kosagisharaf R, Lleonart R, Li C, Goodridge A.
PMID: 33748157
Front Med (Lausanne). 2021 Mar 02;8:616106. doi: 10.3389/fmed.2021.616106. eCollection 2021.

Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, which has reached 28 million cases worldwide in 1 year. The serological detection of antibodies against the virus will...

Cite
Villarreal A, Rangel G, Zhang X, et al. Performance of a Point of Care Test for Detecting IgM and IgG Antibodies Against SARS-CoV-2 and Seroprevalence in Blood Donors and Health Care Workers in Panama. Front Med (Lausanne). 2021;8:616106doi: 10.3389/fmed.2021.616106.
Villarreal, A., Rangel, G., Zhang, X., Wong, D., Britton, G., Fernandez, P. L., Pérez, A., Oviedo, D., Restrepo, C., Carreirra, M. B., Sambrano, D., Eskildsen, G. A., De La Guardia, C., Flores-Cuadra, J., Carrera, J. P., Zaldivar, Y., Franco, D., López-Vergès, S., Zhang, D., Fan, F., Wang, B., Sáez-Llorens, X., DeAntonio, R., Torres-Atencio, I., Blanco, I., Subía, F. D., Mudarra, L., Benzadon, A., Valverde, W., López, L., Hurtado, N., Rivas, N., Jurado, J., Carvallo, A., Rodriguez, J., Perez, Y., Morris, J., Luque, O., Cortez, D., Ortega-Barria, E., Kosagisharaf, R., Lleonart, R., Li, C., & Goodridge, A. (2021). Performance of a Point of Care Test for Detecting IgM and IgG Antibodies Against SARS-CoV-2 and Seroprevalence in Blood Donors and Health Care Workers in Panama. Frontiers in medicine, 8616106. https://doi.org/10.3389/fmed.2021.616106
Villarreal, Alcibiades, et al. "Performance of a Point of Care Test for Detecting IgM and IgG Antibodies Against SARS-CoV-2 and Seroprevalence in Blood Donors and Health Care Workers in Panama." Frontiers in medicine vol. 8 (2021): 616106. doi: https://doi.org/10.3389/fmed.2021.616106
Villarreal A, Rangel G, Zhang X, Wong D, Britton G, Fernandez PL, Pérez A, Oviedo D, Restrepo C, Carreirra MB, Sambrano D, Eskildsen GA, De La Guardia C, Flores-Cuadra J, Carrera JP, Zaldivar Y, Franco D, López-Vergès S, Zhang D, Fan F, Wang B, Sáez-Llorens X, DeAntonio R, Torres-Atencio I, Blanco I, Subía FD, Mudarra L, Benzadon A, Valverde W, López L, Hurtado N, Rivas N, Jurado J, Carvallo A, Rodriguez J, Perez Y, Morris J, Luque O, Cortez D, Ortega-Barria E, Kosagisharaf R, Lleonart R, Li C, Goodridge A. Performance of a Point of Care Test for Detecting IgM and IgG Antibodies Against SARS-CoV-2 and Seroprevalence in Blood Donors and Health Care Workers in Panama. Front Med (Lausanne). 2021 Mar 02;8:616106. doi: 10.3389/fmed.2021.616106. eCollection 2021. PMID: 33748157; PMCID: PMC7968482.
Copy Download .nbib Format: NLM
Showing 1645 to 1647 of 1647 entries